FDA Approved: PROLIA — Supplemental Application (Amgen, Inc)

View source ↗

Summary

FDA approves Amgen's supplemental application for PROLIA (denosumab) to modify the product labeling. The action pertains to updating the label information for t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Prolia (denosumab)

Snippet

SUPPL AP for PROLIA (DENOSUMAB)